Cancers | 2024 Selected Papers Related to Cancer Drug Development

Cancers (ISSN: 2072-6694) is an open access journal, thus granting our readers free and unlimited access to the full text of all articles. We welcome you to read our selected papers related to cancer drug development in 2024, which are listed below.

1. “Antibody–Drug Conjugates: The Dynamic Evolution from Conventional to Next-Generation Constructs”
by Virginia Metrangolo and Lars H. Engelholm
Cancers 2024, 16(2), 447; https://doi.org/10.3390/cancers16020447
Available online: https://www.mdpi.com/2072-6694/16/2/447

2. “Generation of Hydrogen Peroxide in Cancer Cells: Advancing Therapeutic Approaches for Cancer Treatment”
by Taufeeque Ali, Daniel Li, Thilini Nimasha Fernando Ponnamperumage, Alexis Kimberly Peterson, Jatin Pandey, Kulsum Fatima, John Brzezinski, Julia Anna Rose Jakusz, Hanlun Gao, Gilbert Edward Koelsch et al.
Cancers 2024, 16(12), 2171; https://doi.org/10.3390/cancers16122171
Available online: https://www.mdpi.com/2072-6694/16/12/2171

3. “Harnessing Sulforaphane Potential as a Chemosensitizing Agent: A Comprehensive Review”
by Bethsebie Lalduhsaki Sailo, Le Liu, Suravi Chauhan, Sosmitha Girisa, Mangala Hegde, Liping Liang, Mohammed S. Alqahtani, Mohamed Abbas, Gautam Sethi and Ajaikumar B. Kunnumakkara
Cancers 2024, 16(2), 244; https://doi.org/10.3390/cancers16020244
Available online: https://www.mdpi.com/2072-6694/16/2/244

4. “Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive Review”
by Nilesh Kumar Sharma, Anjali Bahot, Gopinath Sekar, Mahima Bansode, Kratika Khuntet, Priyanka Vijay Sonar, Ameya Hebale, Vaishnavi Salokhe and Birandra Kumar Sinha
Cancers 2024, 16(4), 680; https://doi.org/10.3390/cancers16040680
Available online: https://www.mdpi.com/2072-6694/16/4/680

5. “Perioperative Immunosuppressive Factors during Cancer Surgery: An Updated Review”
by Lucillia Bezu, Dilara Akçal Öksüz, Max Bell, Donal Buggy, Oscar Diaz-Cambronero, Mats Enlund, Patrice Forget, Anil Gupta, Markus W. Hollmann, Daniela Ionescu, et al.
Cancers 2024, 16(13), 2304; https://doi.org/10.3390/cancers16132304
Available online: https://www.mdpi.com/2072-6694/16/13/2304

6. “Melatonin and Its Role in the Epithelial-to-Mesenchymal Transition (EMT) in Cancer”
by Carlos Martínez-Campa, Virginia Álvarez-García, Carolina Alonso-González, Alicia González and Samuel Cos
Cancers 2024, 16(5), 956; https://doi.org/10.3390/cancers16050956
Available online: https://www.mdpi.com/2072-6694/16/5/956

7. “Targeting Isocitrate Dehydrogenase (IDH) in Solid Tumors: Current Evidence and Future Perspectives”
by Francesca Carosi, Elisabetta Broseghini, Laura Fabbri, Giacomo Corradi, Riccardo Gili, Valentina Forte, Roberta Roncarati, Daria Maria Filippini and Manuela Ferracin
Cancers 2024, 16(15), 2752; https://doi.org/10.3390/cancers16152752
Available online: https://www.mdpi.com/2072-6694/16/15/2752

8. “A Real-World Study of Patient Characteristics and Clinical Outcomes in EGFR Mutated Lung Cancer Treated with First-Line Osimertinib: Expanding the FLAURA Trial Results into Routine Clinical Practice”
by Hollis Viray, Andrew J. Piper-Vallillo, Page Widick, Emmeline Academia, Meghan Shea, Deepa Rangachari, Paul A. VanderLaan, Susumu S. Kobayashi and Daniel B. Costa
Cancers 2024, 16(6), 1079; https://doi.org/10.3390/cancers16061079
Available online: https://www.mdpi.com/2072-6694/16/6/1079

9. “Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer”
by Xin Gu and Tamara Minko
Cancers 2024, 16(8), 1589; https://doi.org/10.3390/cancers16081589
Available online: https://www.mdpi.com/2072-6694/16/8/1589

10. “Peptide Therapeutics: Unveiling the Potential against Cancer—A Journey through 1989”
by Othman Al Musaimi
Cancers 2024, 16(5), 1032; https://doi.org/10.3390/cancers16051032
Available online: https://www.mdpi.com/2072-6694/16/5/1032

You can view more papers and submit your own manuscript to Cancers via https://www.mdpi.com/journal/cancers.

Cancers Editorial Office